Z-2123-2017 Class II Terminated
FDA device recall Z-2123-2017 was initiated by Merge Healthcare, Inc. on Apr 13, 2016 and is designated Class II. Reason for recall: Fetal patient report was automatically pulling prior measurement data for a prior fetus since the fetal study is based on the mother's MRN, resulting in the wrong fetal measurements getting… The recall status is terminated (terminated Jul 17, 2017). Affected quantity: 30 sites have the potentially affected software versions.
Recall details
- Product Type
- Devices
- Report Date
- May 31, 2017
- Initiation Date
- Apr 13, 2016
- Termination Date
- Jul 17, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 30 sites have the potentially affected software versions
Product description
Merge Cardio software. The firm name on the label is Merge Healthcare, Hartland, WI. Intended to be used to acquire, store, print, transfer, and archive clinical information.
Reason for recall
Fetal patient report was automatically pulling prior measurement data for a prior fetus since the fetal study is based on the mother's MRN, resulting in the wrong fetal measurements getting referenced.
Distribution pattern
Distributed to the states of AZ, CT, FL, GA, IL, IN, LA, MI, NY, NC, OH, OK, TX, and VT.
Code information
Versions 10.0, 10.0.1, 10.1, 10.1.1,10.1.1.1, and 10.1.2.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2123-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026